Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Don’t Believe Everything You Read on Supplement Labels

Don’t believe everything you read on a label – especially if it’s on an herbal supplement bottle. A recent study published in the Journal of Clinical Bioinformatics found four out of five herbal supplements are not what they claim. Unlike prescription drugs, there is no pharmaceutical oversight for herbal supplements. The Food and Drug Administration (FDA) requires companies … Read More

New Pill Can Take the Place of Allergy Shot

Sometime soon, people with severe hay fever will be able to take a prescription pill — rather than receive allergy shots — to control their symptoms. The U.S. Food and Drug Administration this week approved the drug Oralair to treat hay fever that certain grass pollens cause in people ages 10 through 65 years. Oralair is a … Read More

FDA Issues Warning on Concussion Supplements

If it were only that easy: take a pill and avoid a concussion. Problem is, no scientific evidence supports the claim that any dietary supplement is effective in the treatment or prevention of concussion. The Food and Drug Administration (FDA) sent out a strong warning recently about dietary supplements that claim to help you avoid … Read More

Advertising Policy

FDA Mandates New Acetaminophen Warning

Recently, the Food and Drug Administration (FDA) announced that it will require manufacturers of drugs containing acetaminophen to include a new message on drug labels to warn consumers of the connection between acetaminophen and rare, but serious skin reactions that can sometimes be fatal. But despite the dire-sounding warning, the FDA has identified only 107 … Read More

New Breast Cancer Therapy Fast-tracked by FDA

There’s more encouraging news in the battle against breast cancer.  The first pre-surgical drug treatment to treat early stages of breast cancer has been approved by the U.S. Food and Drug Administration (FDA). Availability of the treatment was fast-tracked on the FDA’s accelerated approval program. The quick approval was based on promising results of a … Read More